Diagnosis & Disease Information

In a phase 2 trial, use of the novel oral antiandrogen apalutamide shows promise in patients with very low- to intermediate-risk prostate cancer on active surveillance.

New findings suggest preoperative CKD stage should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy, according to investigators.

Among men with high-risk prostate cancer, delaying radical prostatectomy for up to 12 months is not associated with an increased risk for adverse pathology at the time of surgery compared with those who undergo immediate RP, a study found.

In a subgroup analysis, neither patient characteristics nor prior treatment history influenced response to a novel intravesical gene therapy for BCG-unresponsive bladder cancer.

Patients who received BCG induction within 3 weeks or 3 weeks or more after surgery for nonmuscle-invasive bladder cancer did not differ in their rates of BCG intolerance and recurrence- and progression-free survival, a study found.

This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.

PSA density is routinely collected as part of prostate cancer active surveillance protocols, so monitoring kinetics confers no extra costs or burdens on patients, according to investigators.

A study of patients with metastatic renal cell carcinoma showed that patients with and without bone metastases have similar progression-free and overall survival.